Evaluation of Interventions Based on Behavioral Sciences to Reduce Episiotomy Use
Launched by UNIVERSIDAD PANAMERICANA · Oct 1, 2024
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to reduce the use of episiotomies during childbirth. An episiotomy is a surgical cut made in the vaginal area to help with delivery, and this study will explore how certain strategies, based on behavioral science, can encourage healthcare providers to use fewer episiotomies. These strategies may include providing feedback and sharing information with doctors and nurses to help them make better decisions during labor and delivery.
The trial is not yet recruiting participants, but it will focus on healthcare personnel who are involved in deciding whether to perform an episiotomy in a hospital setting. Unfortunately, those who do not have a role in this decision-making process will not be eligible to participate. While the details about what participants can expect are still being finalized, the goal of this study is to ultimately improve care for mothers and babies by reducing unnecessary surgical procedures during childbirth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthcare personnel involved in decision-making associated with performing episiotomies who work in the hospital selected to pilot the proposed intervention.
- Exclusion Criteria:
- • Healthcare personnel who are not involved in the decision-making process over performing episiotomy during delivery.
About Universidad Panamericana
Universidad Panamericana is a prestigious academic institution dedicated to advancing knowledge and innovation in various fields, including healthcare and medical research. As a clinical trial sponsor, the university is committed to conducting rigorous and ethically sound research that contributes to the development of new therapies and treatments. With a multidisciplinary approach, Universidad Panamericana leverages its extensive resources, expert faculty, and collaborative networks to ensure the highest standards of scientific integrity and patient safety in all its clinical trials, ultimately aiming to enhance public health outcomes and foster advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported